Biotechnology News

Mechelen, Belgium; October 13, 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ:...

Mechelen, België; 13 oktober 2026, 22.01 CET; gereglementeerde informatie In het kader van het op 9 juni 2026 aangekondigde inkoopprogramma maakt Lakefront Biotherapeutics NV (Euronext & NASDAQ:...

SANGAMO THERAPEUTICS LAUNCHES AUCTION PROCESS FOR CLINICAL-STAGE CHRONIC NEUROPATHIC PAIN PROGRAM

The Elite Graft Program combines advanced biologic wound care, reimbursement support, and clawback protection to build provider confidence.

Giraffe Bio raises $6.4M to scale drop-in biochemical flotation reagents that help mines recover more copper without requiring new equipment.

PROTEXT MOBILITY CHAIRMAN CONFIRMS 831.3 MILLION COMMON SHARES IN SEC FILING - CHAIRMAN AND CEO REAFFIRM ZERO PREFERRED CONVERSIONS

Applied Biologics treats first patient in Phase 3 BIOxHEAL™ clinical trial for diabetic foot ulcers.

Mr. Vat-Ho's appointment adds more than 20 years of oncology, biopharma and capital markets experience, including senior roles in transactions totaling more than $25 billion in aggregate value Mr....

23andMe Research Institute names its first Scientific Advisory Board, uniting leaders in genomics, AI, gene editing, and medicine to support its mission.

WARRENDALE, Pa., Oct. 13, 2026 (GLOBE NEWSWIRE) -- ECM Therapeutics, Inc. today announced early clinical results suggesting its extracellular matrix (ECM) hydrogel, ECMT-100, could meaningfully...